Vaginal cuff recurrence after radical cystectomy: An under-studied site of bladder cancer relapse

Fabio Zattoni, Alessandro Morlacco, Avinash Nehra, Igor Frank, Stephen A. Boorjian, Prabin Thapa, Robert Jeffrey Karnes

Research output: Contribution to journalArticle

Abstract

Introduction: Vaginal cuff recurrence of tumor following radical cystectomy is a rare site of disease recurrence, however it has never been specifically studied. The aim of the study is to evaluate incidence, risk factors, and long-term oncologic outcomes of vaginal cuff recurrence in a cohort of female patients treated with radical cystectomy for invasive urothelial carcinoma of the bladder. Materials and Methods: From 1985 to 2012, a prospectively maintained institutional bladder cancer registry was queried for vaginal cuff recurrence post radical cystectomy. Overall mortality and cancer-specific mortality were reported using the Kaplan-Meier method for patients with vaginal cuff recurrence, recurrence at another local or distant site, and those without evidence of recurrence. Comparisons were performed using the log-rank test. Cox proportional hazards regression model was performed to assess predictors of vaginal cuff recurrence. Results: From 469 women treated with radical cystectomy for bladder cancer, 34 patients (7.3%) developed vaginal cuff recurrence, 130 patients (27.7%) had recurrence involving either a local or distant site, and 305 patients (65%) had no evidence of recurrence. The 5-year overall mortality-free survival rate was 32.4% for vaginal cuff recurrence, but 25.0% for other sites of recurrence. Cancer-specific mortality-free survival rate was 32.4% for vaginal cuff recurrence, and 30.3% for the other sites of recurrence. Multivariate Cox proportional hazards regression analysis demonstrated that the presence of tumor in posterior location at radical cystectomy (Hazard Ratio [HR], 0.353 [95% CI, 0.159-0.783]) and anterior vaginectomy, compared to no vaginectomy (HR, 2.595 [95% CI, 1.077-6.249]) were independently associated with vaginal cuff recurrence. Conclusion: Anterior vaginectomy, despite our best attempts, is perhaps not sufficient to prevent vaginal cuff recurrence. Therefore, follow-up evaluation is essential, and further studies are necessary to address the optimal approach for initial management. Patient Summary: Although vaginal cuff recurrence is an unusual site of recurrence, careful evaluation is needed before cystectomy and during follow-up to identify patients at risk.

Original languageEnglish (US)
Pages (from-to)491-499
Number of pages9
JournalInternational Braz J Urol
Volume44
Issue number3
DOIs
StatePublished - May 1 2018

Fingerprint

Cystectomy
Urinary Bladder Neoplasms
Recurrence
Mortality
Neoplasms
Survival Rate

Keywords

  • Female
  • Neoplasm metastasis
  • Recurrence
  • Urinary bladder neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Vaginal cuff recurrence after radical cystectomy : An under-studied site of bladder cancer relapse. / Zattoni, Fabio; Morlacco, Alessandro; Nehra, Avinash; Frank, Igor; Boorjian, Stephen A.; Thapa, Prabin; Karnes, Robert Jeffrey.

In: International Braz J Urol, Vol. 44, No. 3, 01.05.2018, p. 491-499.

Research output: Contribution to journalArticle

Zattoni, Fabio ; Morlacco, Alessandro ; Nehra, Avinash ; Frank, Igor ; Boorjian, Stephen A. ; Thapa, Prabin ; Karnes, Robert Jeffrey. / Vaginal cuff recurrence after radical cystectomy : An under-studied site of bladder cancer relapse. In: International Braz J Urol. 2018 ; Vol. 44, No. 3. pp. 491-499.
@article{68fead9b46814fb99c8ff45d8e8a16e1,
title = "Vaginal cuff recurrence after radical cystectomy: An under-studied site of bladder cancer relapse",
abstract = "Introduction: Vaginal cuff recurrence of tumor following radical cystectomy is a rare site of disease recurrence, however it has never been specifically studied. The aim of the study is to evaluate incidence, risk factors, and long-term oncologic outcomes of vaginal cuff recurrence in a cohort of female patients treated with radical cystectomy for invasive urothelial carcinoma of the bladder. Materials and Methods: From 1985 to 2012, a prospectively maintained institutional bladder cancer registry was queried for vaginal cuff recurrence post radical cystectomy. Overall mortality and cancer-specific mortality were reported using the Kaplan-Meier method for patients with vaginal cuff recurrence, recurrence at another local or distant site, and those without evidence of recurrence. Comparisons were performed using the log-rank test. Cox proportional hazards regression model was performed to assess predictors of vaginal cuff recurrence. Results: From 469 women treated with radical cystectomy for bladder cancer, 34 patients (7.3{\%}) developed vaginal cuff recurrence, 130 patients (27.7{\%}) had recurrence involving either a local or distant site, and 305 patients (65{\%}) had no evidence of recurrence. The 5-year overall mortality-free survival rate was 32.4{\%} for vaginal cuff recurrence, but 25.0{\%} for other sites of recurrence. Cancer-specific mortality-free survival rate was 32.4{\%} for vaginal cuff recurrence, and 30.3{\%} for the other sites of recurrence. Multivariate Cox proportional hazards regression analysis demonstrated that the presence of tumor in posterior location at radical cystectomy (Hazard Ratio [HR], 0.353 [95{\%} CI, 0.159-0.783]) and anterior vaginectomy, compared to no vaginectomy (HR, 2.595 [95{\%} CI, 1.077-6.249]) were independently associated with vaginal cuff recurrence. Conclusion: Anterior vaginectomy, despite our best attempts, is perhaps not sufficient to prevent vaginal cuff recurrence. Therefore, follow-up evaluation is essential, and further studies are necessary to address the optimal approach for initial management. Patient Summary: Although vaginal cuff recurrence is an unusual site of recurrence, careful evaluation is needed before cystectomy and during follow-up to identify patients at risk.",
keywords = "Female, Neoplasm metastasis, Recurrence, Urinary bladder neoplasms",
author = "Fabio Zattoni and Alessandro Morlacco and Avinash Nehra and Igor Frank and Boorjian, {Stephen A.} and Prabin Thapa and Karnes, {Robert Jeffrey}",
year = "2018",
month = "5",
day = "1",
doi = "10.1590/S1677-5538.IBJU.2017.0376",
language = "English (US)",
volume = "44",
pages = "491--499",
journal = "International braz j urol : official journal of the Brazilian Society of Urology",
issn = "1677-5538",
publisher = "Brazilian Society of Urology",
number = "3",

}

TY - JOUR

T1 - Vaginal cuff recurrence after radical cystectomy

T2 - An under-studied site of bladder cancer relapse

AU - Zattoni, Fabio

AU - Morlacco, Alessandro

AU - Nehra, Avinash

AU - Frank, Igor

AU - Boorjian, Stephen A.

AU - Thapa, Prabin

AU - Karnes, Robert Jeffrey

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Introduction: Vaginal cuff recurrence of tumor following radical cystectomy is a rare site of disease recurrence, however it has never been specifically studied. The aim of the study is to evaluate incidence, risk factors, and long-term oncologic outcomes of vaginal cuff recurrence in a cohort of female patients treated with radical cystectomy for invasive urothelial carcinoma of the bladder. Materials and Methods: From 1985 to 2012, a prospectively maintained institutional bladder cancer registry was queried for vaginal cuff recurrence post radical cystectomy. Overall mortality and cancer-specific mortality were reported using the Kaplan-Meier method for patients with vaginal cuff recurrence, recurrence at another local or distant site, and those without evidence of recurrence. Comparisons were performed using the log-rank test. Cox proportional hazards regression model was performed to assess predictors of vaginal cuff recurrence. Results: From 469 women treated with radical cystectomy for bladder cancer, 34 patients (7.3%) developed vaginal cuff recurrence, 130 patients (27.7%) had recurrence involving either a local or distant site, and 305 patients (65%) had no evidence of recurrence. The 5-year overall mortality-free survival rate was 32.4% for vaginal cuff recurrence, but 25.0% for other sites of recurrence. Cancer-specific mortality-free survival rate was 32.4% for vaginal cuff recurrence, and 30.3% for the other sites of recurrence. Multivariate Cox proportional hazards regression analysis demonstrated that the presence of tumor in posterior location at radical cystectomy (Hazard Ratio [HR], 0.353 [95% CI, 0.159-0.783]) and anterior vaginectomy, compared to no vaginectomy (HR, 2.595 [95% CI, 1.077-6.249]) were independently associated with vaginal cuff recurrence. Conclusion: Anterior vaginectomy, despite our best attempts, is perhaps not sufficient to prevent vaginal cuff recurrence. Therefore, follow-up evaluation is essential, and further studies are necessary to address the optimal approach for initial management. Patient Summary: Although vaginal cuff recurrence is an unusual site of recurrence, careful evaluation is needed before cystectomy and during follow-up to identify patients at risk.

AB - Introduction: Vaginal cuff recurrence of tumor following radical cystectomy is a rare site of disease recurrence, however it has never been specifically studied. The aim of the study is to evaluate incidence, risk factors, and long-term oncologic outcomes of vaginal cuff recurrence in a cohort of female patients treated with radical cystectomy for invasive urothelial carcinoma of the bladder. Materials and Methods: From 1985 to 2012, a prospectively maintained institutional bladder cancer registry was queried for vaginal cuff recurrence post radical cystectomy. Overall mortality and cancer-specific mortality were reported using the Kaplan-Meier method for patients with vaginal cuff recurrence, recurrence at another local or distant site, and those without evidence of recurrence. Comparisons were performed using the log-rank test. Cox proportional hazards regression model was performed to assess predictors of vaginal cuff recurrence. Results: From 469 women treated with radical cystectomy for bladder cancer, 34 patients (7.3%) developed vaginal cuff recurrence, 130 patients (27.7%) had recurrence involving either a local or distant site, and 305 patients (65%) had no evidence of recurrence. The 5-year overall mortality-free survival rate was 32.4% for vaginal cuff recurrence, but 25.0% for other sites of recurrence. Cancer-specific mortality-free survival rate was 32.4% for vaginal cuff recurrence, and 30.3% for the other sites of recurrence. Multivariate Cox proportional hazards regression analysis demonstrated that the presence of tumor in posterior location at radical cystectomy (Hazard Ratio [HR], 0.353 [95% CI, 0.159-0.783]) and anterior vaginectomy, compared to no vaginectomy (HR, 2.595 [95% CI, 1.077-6.249]) were independently associated with vaginal cuff recurrence. Conclusion: Anterior vaginectomy, despite our best attempts, is perhaps not sufficient to prevent vaginal cuff recurrence. Therefore, follow-up evaluation is essential, and further studies are necessary to address the optimal approach for initial management. Patient Summary: Although vaginal cuff recurrence is an unusual site of recurrence, careful evaluation is needed before cystectomy and during follow-up to identify patients at risk.

KW - Female

KW - Neoplasm metastasis

KW - Recurrence

KW - Urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85049039842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049039842&partnerID=8YFLogxK

U2 - 10.1590/S1677-5538.IBJU.2017.0376

DO - 10.1590/S1677-5538.IBJU.2017.0376

M3 - Article

C2 - 29244270

AN - SCOPUS:85049039842

VL - 44

SP - 491

EP - 499

JO - International braz j urol : official journal of the Brazilian Society of Urology

JF - International braz j urol : official journal of the Brazilian Society of Urology

SN - 1677-5538

IS - 3

ER -